Live from the NIH registry
Studies recruiting near Albuquerque right now
Top 25 of 340 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Medtronic
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Presbyterian Kaseman Hospital (site 208) — Albuquerque, New Mexico (1.5 mi)
· Sponsor: VM Oncology, LLC
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Lovelace Health System — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Renal Medicine Associates — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
MDMA for Co-occurring PTSD and OUD After Childbirth
Stress Disorders, Post-Traumatic, Opioid Use Disorder
Phase 2
Interventional 15 participants sought
University of New Mexico Health Sciences — Albuquerque, New Mexico (1.5 mi)
· Sponsor: University of New Mexico
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma
Phase 1
Interventional 65 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
New Mexico Oncology Hematology — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Novartis Pharmaceuticals
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
292 — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Corcept Therapeutics
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Sameek Roychowdhury
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Parkinson's Foundation
Distal Radius Interventions for Fracture Treatment
Fracture Distal Radius
N/A
Interventional 334 participants sought
University of New Mexico - Carrie Tingley — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Jaeb Center for Health Research
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
University of New Mexico Comprehensive Cancer Center ( Site 6046) — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Secondary Progressive Multiple Sclerosis
Phase 3
Interventional 990 participants sought
University Of New Mexico School Of Medicine — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Zenas BioPharma (USA), LLC
Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study
Decision-Making, Patient Care
Phase 2
Interventional 210 participants sought
University of New Mexico Health Sciences Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: University of Arkansas, Fayetteville
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Raymond G. Murphy VA — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
Convergence Insufficiency, Traumatic Brain Injury
N/A
Interventional 100 participants sought
New Mexico VA Health Care System — Albuquerque, New Mexico (1.5 mi)
· Sponsor: New Jersey Institute of Technology
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Rectal Cancer
Phase 3
Interventional 250 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Canadian Cancer Trials Group
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: NRG Oncology
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: NRG Oncology
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Pfizer
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 218 participants sought
New Mexico Oncology Hematology Consultants — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Trial of Underwater Birth
Birth
N/A
Interventional 230 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: University of New Mexico